VAERS Explorer
Back to explore

Report #2856089

Received Aug 29, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECHUNK——

Symptoms (1)

Chronic inflammatory demyelinating polyradiculoneuropathy

Symptom narrative

COVID-19 vaccine-related Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP); This is a spontaneous report received from a Consumer or other non HCP. An adolescent female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (medically significant), outcome "unknown", described as "COVID-19 vaccine-related Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)". The clinical course was reported as follows: PANZYGA was prescribed for CIDP, start date: 01Feb2021. Therapeutic measures were taken as a result of chronic inflammatory demyelinating polyradiculoneuropathy. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.